Shopping Cart
Total:
$0.00
In May 2026, the global medical community officially renamed Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome - PMOS. The change was not cosmetic. It was a scientific correction that repositions one of the most common conditions in women's health as a metabolic disease, not just a reproductive one. For the significant number of women who have both PMOS and migraines, the overlap is worth understanding, because both conditions share the same metabolic underpinnings, and addressing one without the other leaves half the picture untreated.
By entering your email, you agree to our Terms of Service and Privacy Policy.